| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 09/27/2007 | WO2007065095A3 System and method for supporting a biological chip device |
| 09/27/2007 | WO2007059492A3 Detection method for human pappilomavirus (hpv) and its application in cervical cancer |
| 09/27/2007 | WO2007047907A3 Dek protein compositions and methods of using the same |
| 09/27/2007 | WO2007041282A3 Methods and compositions for treatment of cystic fibrosis |
| 09/27/2007 | WO2007038627A3 Stabilized antimicrobial compositions and related methods of preparation |
| 09/27/2007 | WO2006127675A3 Nanoparticles and method to control nanoparticle spacing |
| 09/27/2007 | WO2006091444A8 Diagnostic methods for early cancer detection |
| 09/27/2007 | WO2006078278A3 Single-stranded and double-stranded oligonucleotides comprising a 2-arylpropyl moiety |
| 09/27/2007 | WO2006017318A3 Methods for treating cancer using agents that inhibit wnt16 signaling |
| 09/27/2007 | WO2005099751A3 Apparatus and method for transdermal delivery of influenza vaccine |
| 09/27/2007 | WO2005042763A3 Optimization of gene expression analysis using immobilized capture probes |
| 09/27/2007 | WO2005003370A3 Methods for enhancing gene expression analysis |
| 09/27/2007 | WO2003078662A9 Gene expression profiling in biopsied tumor tissues |
| 09/27/2007 | US20070226815 Protein with immunomodulatory activity, antiviral activity, and antitumor activity encoded by a IFN-alpha upregulated gene; treating any Type 1 interferon treatable disease including cancer; determining if a patient will respond to interferon treatment; transgenic animals, primers, probes, antibodies |
| 09/27/2007 | US20070225583 Method for determining the concentration of blood glucose |
| 09/27/2007 | US20070225487 Nucleic acid detection medium |
| 09/27/2007 | US20070225480 small ubiquitin-like modifier (SUMO); for diagnosis and treatment of Type 1 diabetes |
| 09/27/2007 | US20070225363 Methods and Agents for Inhibiting Dynamin-Dependent Endocytosis |
| 09/27/2007 | US20070225361 Dimeric compounds and their use as anti-viral agents |
| 09/27/2007 | US20070225296 Arylalkylamine Compound and Process for Preparing the Same |
| 09/27/2007 | US20070225283 Conformationally restricted urea inhibitors of soluble epoxide hydrolase |
| 09/27/2007 | US20070225244 Compositions comprising genome segments and methods of using the same |
| 09/27/2007 | US20070225228 Blockade of gamma-secretase activity to promote myelination by oligodendrocytes |
| 09/27/2007 | US20070225227 Lipoparticles comprising ion channels, methods of making and using the same |
| 09/27/2007 | US20070225222 Use of heparin-binding domain of fibronectin for diagnosis and treatment of cancer |
| 09/27/2007 | US20070225218 Extracellular Messengers |
| 09/27/2007 | US20070225205 Interferon-alpha polypeptides and conjugates |
| 09/27/2007 | US20070225204 Interferon-alpha polypeptides and conjugates |
| 09/27/2007 | US20070224695 reacting a fluorescent dye comprising an azide-substituted coumarin and optionally bonded to a biomaterial, with a linkage compound comprising an optionally substituted ethynylbenzene, to form a linkage complex having a fluorescent signal; bioconjugation |
| 09/27/2007 | US20070224685 Reagent Containing Protease Reaction Promoter and/or Colorant Stabilizer |
| 09/27/2007 | US20070224679 Lentiviral triplex DNA, and vectors and recombinant cells containing lentiviral triplex DNA |
| 09/27/2007 | US20070224660 Method for Assessment of Cytotoxic T Lymphocyte Activity |
| 09/27/2007 | US20070224659 Harmful Substance Evaluating Method and Harmful Substance Evaluation Kit |
| 09/27/2007 | US20070224658 Cell Growth |
| 09/27/2007 | US20070224657 Distribution of PON1 as a marker of lipid related disorders |
| 09/27/2007 | US20070224656 Modulation of Abeta levels by beta-secretase BACE2 |
| 09/27/2007 | US20070224655 Methyltransferase assays |
| 09/27/2007 | US20070224647 Monitor protein for measuring processing of protein |
| 09/27/2007 | US20070224644 Ocular fluid markers |
| 09/27/2007 | US20070224642 Supercritical fluid chromatography enables the observation of fast exchanging hydrogen atoms missed using conventional liquid chromatography methods; step in drug design |
| 09/27/2007 | US20070224638 Secreted proteins as early markers and drug targets for autoimmunity, tumorigenesis and infections |
| 09/27/2007 | US20070224635 Regulated Stop Codon Readthrough |
| 09/27/2007 | US20070224632 Device and method for high-throughput quantification of mRNA from whole blood |
| 09/27/2007 | US20070224631 Device and method for high-throughput quantification of mRNA from whole blood |
| 09/27/2007 | US20070224630 Compositions and methods of selective nucleic acid isolation |
| 09/27/2007 | US20070224629 Laser exposure of photosensitive masks for dna microarray fabrication |
| 09/27/2007 | US20070224628 Protein isoform discrimination and quantitative measurements thereof |
| 09/27/2007 | US20070224626 Comprehensive DNA methylation profiling in a human cancer genome identifies novel epigenetic targets |
| 09/27/2007 | US20070224625 Site-specific enzymatic deposition of metal in situ |
| 09/27/2007 | US20070224624 Nucleic acid encoding spinocerebellar ataxia-2 and products related thereto |
| 09/27/2007 | US20070224623 Simplified QTL mapping approach for screening and mapping novel markers associated with beef marbling |
| 09/27/2007 | US20070224621 Reporter enzyme activity evaluated using a secondary reporter system which employs a product of a reporter enzyme-mediated reaction as a luminescent substrate, e.g., luciferase substrate; in vivo testing of gene expression, monitoring circulating factors, detecting extracellular antigen expression |
| 09/27/2007 | US20070224620 Compositions and methods for capturing and analyzing cross-linked biomolecules |
| 09/27/2007 | US20070224619 includes a blood test that measures an Apo E genotype from the patient to generate Apo B information; using the information as data tool in designing physical regimen to prevent and/or alleviate cardiovascular disorders |
| 09/27/2007 | US20070224617 Mechanically induced trapping of molecular interactions |
| 09/27/2007 | US20070224616 Method for forming molecular sequences on surfaces |
| 09/27/2007 | US20070224615 Methods for assaying protein-protein interactions |
| 09/27/2007 | US20070224614 Compositions for use in identification of bacteria |
| 09/27/2007 | US20070224613 Massively Multiplexed Sequencing |
| 09/27/2007 | US20070224612 sterically demanding nucleotide intercalators; measuring fluorescence of complexes formed; compounds catalyze photolytic cleavage of polynucleotide duplex having a base-pair mismatch; kit; photoexcitable metal complexes with aryl rings and two imines; linked to cytotoxic agent for site targeted therapy |
| 09/27/2007 | US20070224611 Inactivation method |
| 09/27/2007 | US20070224610 Method of quantifying hiv-1 rna-dna hydrid and diagnosis kit |
| 09/27/2007 | US20070224609 Genotoxic Testing |
| 09/27/2007 | US20070224608 Recombinant 12-KDA protein useful for the detection of respiratory allergies |
| 09/27/2007 | US20070224606 Mn/Ca Ix/Ca9 and Renal Cancer Prognosis |
| 09/27/2007 | US20070224605 Method for Preparing a Dna Chip and Use Thereof |
| 09/27/2007 | US20070224604 Method of Determining the Presence and/or Concentration of Substances of Interest in Fluids |
| 09/27/2007 | US20070224603 Cleaving a polynucleotide from a substrate in compositions having a polynucleotide bound to a substrate via a cleavable linker by contact with an alpha -effect nucleophile |
| 09/27/2007 | US20070224602 Thiocarbonate linkers for polynucleotides |
| 09/27/2007 | US20070224601 Quantification of depurination through the use of two cleavage sites |
| 09/27/2007 | US20070224600 Immunohistochemical assay for detecting kidney or colorectal cancer is based on the relative absence of labeled antibody binding to cancerous tissue compared with normal tissue |
| 09/27/2007 | US20070224599 Interaction of stressful life events and a serotonin transporter polymorphism in the prediction of episodes of major depression |
| 09/27/2007 | US20070224598 System and method for detection of mutations in JAK2 polynucleotides |
| 09/27/2007 | US20070224597 Isolating fetal trophoblasts |
| 09/27/2007 | US20070224596 Compositions and methods for the modifying hypoxia induced gene regulation |
| 09/27/2007 | US20070224595 Nucleic acid molecules and other molecules associated with plants |
| 09/27/2007 | US20070224594 Contacting a sample from the subject with a PDZ polypeptides (PDZ) and/or PDZ ligands (PL) and determining whether binding interactions occur between PDZ and PL |
| 09/27/2007 | US20070224593 Diagnosis of transmissible spongiform encephalopathy |
| 09/27/2007 | US20070224591 Rotation-based microsampler, system and method of using the same |
| 09/27/2007 | US20070224590 Single cell planar chromatography |
| 09/27/2007 | US20070224490 Suspension for the Generation of a Current of Electrons and the Use and the Preparation Thereof |
| 09/27/2007 | US20070224273 Multifunctional Supramolecular Hydrogels as Biomaterials |
| 09/27/2007 | US20070224257 Brucellosis dna vaccine |
| 09/27/2007 | US20070224223 Methods for the in vitro culture of sporozoea sp. and uses thereof |
| 09/27/2007 | US20070224217 Virulence genes of M. marinum and M. tuberculosis |
| 09/27/2007 | US20070224212 for therapeutic treatment against HIV infection by inhibiting the virus-host cell membrane fusion process; inhibitors of HIV infectivity |
| 09/27/2007 | US20070224210 Immunostimulatory nucleic acids |
| 09/27/2007 | US20070224206 Inactivating Organisms Using Carbon Dioxide at or Near its Supercritical Pressure and Temperature Conditions |
| 09/27/2007 | US20070224201 Maytansinoid conjugated immunoglobulin for use in prevention, detection and treatment of cell proliferative disorders |
| 09/27/2007 | US20070224200 Gm3 Synthase as a Therapeutic Target in Microvascular Complications of Diabetes |
| 09/27/2007 | US20070224199 Targeting of MKRN1 for Identifying Cancer Treatment Agents |
| 09/27/2007 | US20070224185 Secreted and Transmembrane Polypeptides and Nucleic Acids Encoding the Same |
| 09/27/2007 | US20070224181 inducer of hemopoietic cell differentiation and expansion for granulocytic population, thrombopoietin and pro-inflammatory cytokines; for pre-transplant priming of hematopoietic stem cells; chronic stress, autoimmune diseases, inflammation, rheumatoid arthritis, multiple sclerosis, fibromyalgia |
| 09/27/2007 | US20070224127 Cardiovascular disorders such as myocardial infarction, post-myocardial infarction remodeling, and congestive heart failure |
| 09/27/2007 | US20070224125 Polypeptide of given sequence; transforming or transfecting cell with expression vector; inhibits tumor necrosis factor release; anti-inflammatory |
| 09/27/2007 | US20070224123 Proteins expressed by mycobacterium tuberculosis and not by bcg and their use as diagnostic reagents and vaccines |
| 09/27/2007 | US20070224122 Method of in vitro diagnosis which discriminates between exposure of a subject to Mycobacterium tuberculosis and vaccination with Bacille Calmette Guerin strain of Mycobacterium bovis, method comprising testing for presence of CD4 T lymphocytes that respond to MTBN4 |
| 09/27/2007 | US20070224084 Systems and Methods of Sample Processing and Fluid Control in a Fluidic System |
| 09/27/2007 | DE102006014193A1 Verwendung des 4-1BB Rezeptors zur Identifizierung und/oder Separation aktivierter regulatorischer Th-Zellen (Treg) Use of the 4-1BB receptor for identifying and / or separation of activated regulatory Th cells (Treg) |
| 09/27/2007 | DE102004049891B4 Verfahren zum Identifizieren von geeigneten Nukleinsäurenormalisierungssondensequenzen zur Verwendung bei Nukleinsäurearrays A method of identifying suitable nucleic acid probe sequences for use in normalization nucleic acid arrays |